Stock Analysis
- China
- /
- Personal Products
- /
- SHSE:603193
Three High-Growth Chinese Stocks With Up To 33% Insider Ownership On The SSE
Reviewed by Simply Wall St
As global markets experience fluctuations, China's stock market has shown mixed signals with sectors like real estate continuing to struggle, while retail sales exhibit growth. In such a varied economic landscape, companies with high insider ownership can be appealing as they often indicate a strong commitment by those who know the business best.
Top 10 Growth Companies With High Insider Ownership In China
Name | Insider Ownership | Earnings Growth |
Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) | 24% | 22.3% |
KEBODA TECHNOLOGY (SHSE:603786) | 12.8% | 25.1% |
Ningbo Deye Technology Group (SHSE:605117) | 24.8% | 28.5% |
Cubic Sensor and InstrumentLtd (SHSE:688665) | 10.1% | 34.3% |
Anhui Huaheng Biotechnology (SHSE:688639) | 31.5% | 28.4% |
Sineng ElectricLtd (SZSE:300827) | 36.5% | 39.8% |
Arctech Solar Holding (SHSE:688408) | 38.6% | 25.8% |
Eoptolink Technology (SZSE:300502) | 26.7% | 39.1% |
UTour Group (SZSE:002707) | 24% | 33.1% |
Xi'an Sinofuse Electric (SZSE:301031) | 36.8% | 43.1% |
Let's review some notable picks from our screened stocks.
Runben Biotechnology (SHSE:603193)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Runben Biotechnology Co., Ltd. operates in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products with a market capitalization of approximately CN¥7.53 billion.
Operations: The company generates its revenue primarily from personal products, totaling CN¥1.05 billion.
Insider Ownership: 33.1%
Runben Biotechnology is poised for robust growth with earnings expected to increase by 22.43% annually, outpacing the Chinese market's forecast of 22.2%. Revenue growth projections are even more optimistic at 25.5% per year, significantly above the market average of 13.7%. However, its Return on Equity is anticipated to be modest at 15.3% in three years. Recent financials show a strong uptrend with sales and net income rising notably in Q1 2024 compared to the previous year, supporting these growth expectations despite an unstable dividend track record.
- Navigate through the intricacies of Runben Biotechnology with our comprehensive analyst estimates report here.
- Our valuation report unveils the possibility Runben Biotechnology's shares may be trading at a premium.
FriendLtd (SHSE:605050)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: FriendLtd (ticker: SHSE:605050) is a company that offers steel logistics supply chain services primarily to the automotive and home appliance sectors, with a market capitalization of CN¥4.58 billion.
Operations: The company generates revenue primarily through its metal processors and fabrication segment, totaling CN¥10.02 billion.
Insider Ownership: 32.4%
FriendLtd, a Chinese growth company with high insider ownership, reported a slight decline in net income to CNY 76.71 million in Q1 2024 from CNY 85.31 million year-over-year, despite a revenue increase to CNY 2,392.26 million from CNY 2,131.63 million. The firm's earnings are projected to grow by 25.56% annually over the next three years, outstripping the Chinese market's growth rate of 22.2%. However, its dividend sustainability is questionable as it is not well covered by cash flows.
- Dive into the specifics of FriendLtd here with our thorough growth forecast report.
- Insights from our recent valuation report point to the potential undervaluation of FriendLtd shares in the market.
Zhejiang Jinke Tom Culture Industry (SZSE:300459)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Zhejiang Jinke Tom Culture Industry Co., Ltd. operates in the cultural industry in China, focusing on the production and distribution of various cultural products, with a market capitalization of approximately CN¥11.95 billion.
Operations: The company generates revenue primarily from the mobile internet cultural industry, totaling CN¥1.30 billion.
Insider Ownership: 17.2%
Zhejiang Jinke Tom Culture Industry, a Chinese company with high insider ownership, is poised for significant growth with its revenue expected to increase by 28% annually. This growth rate surpasses the broader Chinese market's average of 13.7%. While the company's share price has shown considerable volatility recently, earnings are projected to surge by 116.39% per year. Despite recent dips in quarterly net income and revenue as reported in April 2024, the firm is anticipated to become profitable within three years.
- Click here to discover the nuances of Zhejiang Jinke Tom Culture Industry with our detailed analytical future growth report.
- Our valuation report here indicates Zhejiang Jinke Tom Culture Industry may be overvalued.
Turning Ideas Into Actions
- Unlock our comprehensive list of 367 Fast Growing Chinese Companies With High Insider Ownership by clicking here.
- Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
- Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SHSE:603193
Runben Biotechnology
Engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products.